RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

MODULATION OF STAT 6 EXPRESSION FOR THE TREATMENT OF AIRWAY HYPERRESPONSIVENESS

Methods to reprogram splice site selection in pre-messenger RNAs

Interfering RNA molecules

RNA sequence-specific mediators of RNA interference

Small internally segmented interfering RNA

METHOD OF TREATING NEURODEGENERATIVE DISEASE

Methods and compositions involving miRNA and miRNA inhibitor molecules

Complex for transferring an anionic substance into a cell

Modulation of C-reactive protein expression

Nucleic acid capable of binding to immunoglobulin G and use thereof

Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)

Novel siRNAS and methods of use thereof

DBAIT and uses thereof

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

MODULATION OF ENDOTHELIAL LIPASE EXPRESSION

RNA INTERFERENCE MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNAi inhibition of alpha-ENaC expression

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

Antiviral oligonucleotides targeting viral families

Novel siRNAS and methods of use thereof

RNA Interference Mediating Small RNA Molecules

Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

MicroRNAs

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

Compositions and methods for inhibiting expression of a gene from the Ebola

Cell transfecting formulations of small interfering RNA related compositions and methods of making and use

Transcription factor decoy

RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)

RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF ANGIOPOIETIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)

Methods and compositions for regulating cell cycle progression via the miR-106B family

Tripartite RNAi constructs

Antisense modulation of PTP1B expression

MODULATION OF INSULIN LIKE GROWTH FACTOR I RECEPTOR EXPRESSION

NUCLEIC ACIDS HYBRIDIZABLE TO MICRO RNA AND PRECURSORS THEREOF

Antisense microRNA and uses therefor

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF MYOSTATIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

Antiviral oligonucleotides

RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)

RNAi modulation of SCAP and therapeutics uses thereof

Compositions and methods to stack multiple nucleotide sequences of interest in the genome of a plant

Modulating Gene Expression with agRNA and Gapmers Targeting Antisense Transcripts

Enhanced retinal delivery of a nucleic acid through iontophoresis

Sequence-specific inhibition of small RNA function

Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics

Modulation of eIF4E-BP2 expression

Modulation of transthyretin expression

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

Modulation of apolipoprotein (a) expression

Metabolic profile directed aptamer medicinal chemistry

Compositions and methods for inhibiting expression of a gene from the JC virus

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Stabilized Aptamers to Platelet Derived Growth Factor and their Use as Oncology Therapeutics

Oligonucleotide modulation of cell adhesion

MicroRNA and methods for inhibiting same

Antiviral oligonucleotides targeting HBV

DOUBLE-STRANDED LOCKED NUCLEIC ACID COMPOSITIONS

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

RNA interference in respiratory epithelial cells

Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions

RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Double-Stranded Oligonucleotides

MODIFICATION OF DOUBLE-STRANDED RIBONUCLEIC ACID MOLECULES

Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease Therapeutics

Antisense oligonucleotides for prevention of metastasis formation of cancer cells

Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions

Method for generating aptamers with improved off-rates

Method for modulating responsiveness to steroids

Isis Pharmaceuticals, Inc.

Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial

Tandem siRNAS

NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF

Synthetic agonists of TLR9

Pharmaceutical Composition Containing Meltrin Antagonist

Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases

Oligonucleotide complex compositions and methods of use as gene alteration tools

Methods of nonspecific target capture of nucleic acids

Compositions and their uses directed to PTPRU

RNAi probes targeting cancer-related proteins

Lipids, lipid complexes and use thereof

RNA interference mediating small RNA molecules

Chimeric Gapped Oligomeric Compounds

Compositions and methods for the modulation of JNK proteins

Norovirus detection, methods and compositions therefor

RNA Interference Mediated Inhibition of Gene Expression Using Short Interfering Nucleic Acid (siNA)

Modified siRNA molecules and uses thereof

Genetic inhibition of double-stranded RNA

Modified polynucleotides for reducing off-target effects in RNA interference

Antisense modulation of apolipoprotein B expression

Materials and methods for treatment of cancer

Methods and compositions for reducing viral genome amounts in a target cell

Oligonucleotide-containing pharmacological compositions and their use

Compositions and methods for inhibiting expression of Huntingtin gene

Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant

Induction of exon skipping in eukaryotic cells

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

Compositions and methods for optimizing cleavage of RNA by RNase H

Method For Preventing or Treating Pain in a Mammal

Modulation of T cell signaling threshold and T cell sensitivity to antigens

Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Methods for the Delivery of Oligomeric Compounds

Antisense modulation of p38 mitogen activated protein kinase expression

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Synthetic siRNA compounds and methods for the downregulation of gene expression

ANTISENSE MODULATION OF ACYL COA CHOLESTEROL ACYLTRANSFERASE-2 EXPRESSION

Methods and compositions involving miRNA and miRNA inhibitor molecules

NUCLEIC ACID MODULATION OF TOLL-LIKE RECEPTOR-MEDIATED IMMUNE STIMULATION

Methods and compositions involving miRNA and miRNA inhibitor molecules

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

Modulation of FR-alpha expression

Oligonucleotide-containing pharmacological compositions and their use

Oligonucleotide-containing pharmacological compositions and their use

Modulators of coagulation factors

Treatment of neurological disorders by dsRNA administration

Modulation of forkhead box O1A expression

Antisense modulation of stearoyl-CoA desaturase expression

Positionally modified siRNA constructs

RNA sequence-specific mediators of RNA interference

Modulators of coagulation factors with enhanced stability

Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation

Compositions and methods for the treatment of muscle wasting

Clusterin antisense therapy for treatment of cancer

Compositions and methods for inhibiting expression of the PCSK9 gene

Lipophilic conjugated iRNA agents

Compositions and methods for inhibiting expression of IKK-B gene

Compounds and Their Use for Specific and Simultaneous Inhibition of Genes Involved In Diseases and Related Drugs

COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA

MODULATION OF GENE EXPRESSION USING DNA-RNA HYBRIDS

Duplex oligonucleotide complexes and methods for gene silencing by RNA interference

Genetic inhibition by double-stranded RNA

miRNA of HSV-LAT and uses thereof

TRPM-2 antisense therapy

Therapeutic uses of inhibitors of RTP801L

G-rich polynucleotides as a novel therapeutic for the treatment of huntington's disease

ANTISENSE OLIGONUCLEOTIDE MODULATION OF STAT3 EXPRESSION

Modulators of pharmacological agents

Methods and compositions involving miRNA and miRNA inhibitor molecules

Genetic inhibition by double-stranded RNA

POLYCYCLIC SUGAR SURROGATE-CONTAINING OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATION

Compositions and their uses directed to huntingtin

RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS

Polycationic compositions for cellular delivery of polynucleotides

2'-MODIFIED OLIGONUCLEOTIDES

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

Short antisense compounds with gapmer configuration

RNAi modulation of TGF-beta and therapeutic uses thereof

Antisense modulation of kinesin-like 1 expression

BACKBONE MODIFICATIONS TO MODULATE OLIGONUCLEOTIDE TARGETING IN VIVO

COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN

Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA

Pharmaceutical Compositions and Methods for Reducing Body Fat

Modulation of STAT5 expression

COMPLEXES AND METHODS OF FORMING COMPLEXES OF RIBONUCLEIC ACIDS AND PEPTIDES

Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial

Human RNase H1 oligonucleotide compositions thereof

Anti-microRNA oligonucleotide molecules

Compositions and methods for inhibiting expression of Eg5 gene

Therapeutic compositions

Compositions and their uses directed to hepcidin

THERAPEUTIC DRUG COMBINATIONS AND DELIVERY SYSTEMS COMPRISING C-RAF KINASE ANTISENSE POLYNUCLEOTIDES FOR TREATING OCULAR DISEASES AND DISORDERS

Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent

Compositions and methods for modulation of Mcl-1 expression

DOUBLE STRANDED NUCLEIC ACID MOLECULES TARGETED TO IL-4 RECEPTOR ALPHA

Modulation of telomere length by oligonucleotides having a G-core sequence

Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid

Stabilized siRNAs as transfection controls and silencing reagents

MODULATION OF THYROID HORMONE RECEPTOR INTERACTOR 3 EXPRESSION

COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX

Compositions and methods for non-parenteral delivery of oligonucleotides

Compounds and Methods for Rna Interference of the P65 Subunit of Nf-Kappa-B

Soluble TNF receptors and their use in treatment of disease

Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity

Modulation of glucagon receptor expression

MODULATION OF GLUCAGON RECEPTOR EXPRESSION

MODULATION OF GLUCAGON RECEPTOR EXPRESSION

MODULATION OF GLUCAGON RECEPTOR EXPRESSION

MODULATION OF ACE2 EXPRESSION

Modified triple-helix forming oligonucleotides for targeted mutagenesis

siRNA silencing of influenza virus gene expression

Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

Interfering Rna Duplex Having Blunt-Ends And 3'-Modifications

Data correction apparatus, data correction method, magnetic resonance imaging apparatus and X-ray CT apparatus

RNA interference mediated inhibition of histone deacetylase (HDAC) gene expression using short interfering nucleic acid (siNA)

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Modulation of ace2 expression

Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Protected monomers

Antisense IAP nucleobase oligomers and uses thereof

MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Antisense oligonucleotides (ODN) against Smad7 and uses in medical field thereof

Modified polynucleotides for use in rna interference

Compositions and methods for the treatment of influenza infection

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

Method of treating neurodegenerative disease

COMPOSITIONS AND THEIR USES DIRECTED TO IL-4R ALPHA

Compositions and their uses directed to IL-4R alpha

Methods and compositions for treating neurological disease

Antisense modulation of CD40 expression

Modulation of survivin expression

Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression

RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis

RNAi modulation of HIF-1 and therapeutic uses thereof

Antisense IAP oligonucleotides and uses thereof

Antisense IAP nucleobase oligomers and uses thereof

Compositions and methods for the modulation of the expression of B7 protein

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

Antisense IAP oligonucleotides and uses thereof

Oligonucleotides targeting prion diseases

Methods for slowing familial ALS disease progression

Materials and methods for the generation of fully 2′-modified nucleic acid transcripts

Modulation of gene expression by oligomers targeted to chromosomal DNA

Dbait and uses thereof

RNA interference

Modulators of coagulation factors with enhanced stability

Inhibition of histone deacetylase

Splice switch oligomers for TNF superfamily receptors and their use in treatment of disease

Compositions and methods for inhibiting expression of Nav1.8 gene

G-rich polynucleotides for the treatment of Huntington's Disease

Methods and compositions for treating neurological disease

Compositions and methods for inhibiting expression of Huntingtin gene

RNA interference mediating small RNA molecules

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

Modulation of glucagon receptor expression

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

Modulation of glucocorticoid receptor expression

Aptamer medicinal chemistry

Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics

Modulation of eIF4E expression

Pure miRNA Sample Preparation Method

Method and apparatus to facilitate transmission of an encrypted rolling code

Antisense modulation of superoxide dismutase 1, soluble expression

Methods for use in modulating miR-122a

Antisense modulation of fibroblast growth factor receptor 3 expression

Antisense IAP nucleobase oligomers and uses thereof

RNA interference mediated inhibition of 11 beta-hydroxysteroid dehydrogenase-1 (11 beta-HSD-1) gene expression using short interfering nucleic acid siNA

Aptamer therapeutics useful in the treatment of complement-related disorders

RNAi modulation of the Rho-A gene in research models

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

iRNA agents targeted to the Rho-A gene

Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)

Antisense IAP nucleobase oligomers and uses thereof

Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)

Small interfering RNA with improved activity

Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies

Modulation of SOCS-3 expression

Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor

Modulation of HIF1alpha and HIF2alpha expression

Modulation of endothelial lipase expression

Antiviral oligonucleotides having a conserved G4 core sequence

Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation

Nucleic acid ligands to integrins

Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics

Antisense permeation enhancers

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)